Diclofenac Sodium Topical Gel, 1%
AM-DCG-001
Phase 3 small_molecule completed
Quick answer
Diclofenac Sodium Topical Gel, 1% for Osteoarthritis is a Phase 3 program (small_molecule) at Amneal Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Amneal Pharmaceuticals
- Indication
- Osteoarthritis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed